Logo image of DSM.CA

DEEP-SOUTH RESOURCES INC (DSM.CA) Stock Fundamental Analysis

TSX-V:DSM - CA24378W1032 - Common Stock

0.08 CAD
0 (0%)
Last: 3/20/2024, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, DSM scores 2 out of 10 in our fundamental rating. DSM was compared to 791 industry peers in the Metals & Mining industry. DSM has a great financial health rating, but its profitability evaluates not so good. DSM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DSM had negative earnings in the past year.
DSM had a negative operating cash flow in the past year.
In the past 5 years DSM always reported negative net income.
DSM had a negative operating cash flow in each of the past 5 years.
DSM.CA Yearly Net Income VS EBIT VS OCF VS FCFDSM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -2M -4M -6M -8M

1.2 Ratios

Looking at the Return On Assets, with a value of -712.26%, DSM is doing worse than 95.45% of the companies in the same industry.
Looking at the Return On Equity, with a value of -753.87%, DSM is doing worse than 85.01% of the companies in the same industry.
Industry RankSector Rank
ROA -712.26%
ROE -753.87%
ROIC N/A
ROA(3y)-255.92%
ROA(5y)-158.24%
ROE(3y)-281.31%
ROE(5y)-174.67%
ROIC(3y)N/A
ROIC(5y)N/A
DSM.CA Yearly ROA, ROE, ROICDSM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 200 -200 400 -400 -600

1.3 Margins

DSM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DSM.CA Yearly Profit, Operating, Gross MarginsDSM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022

More info and screens

8

2. Health

2.1 Basic Checks

DSM has more shares outstanding than it did 1 year ago.
There is no outstanding debt for DSM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DSM.CA Yearly Shares OutstandingDSM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M
DSM.CA Yearly Total Debt VS Total AssetsDSM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 97.07 indicates that DSM is not in any danger for bankruptcy at the moment.
DSM has a better Altman-Z score (97.07) than 94.47% of its industry peers.
There is no outstanding debt for DSM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 97.07
ROIC/WACCN/A
WACCN/A
DSM.CA Yearly LT Debt VS Equity VS FCFDSM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

A Current Ratio of 8.46 indicates that DSM has no problem at all paying its short term obligations.
DSM has a better Current ratio (8.46) than 79.12% of its industry peers.
A Quick Ratio of 8.46 indicates that DSM has no problem at all paying its short term obligations.
With a decent Quick ratio value of 8.46, DSM is doing good in the industry, outperforming 79.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.46
Quick Ratio 8.46
DSM.CA Yearly Current Assets VS Current LiabilitesDSM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

DSM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -424.93%.
EPS 1Y (TTM)-424.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.21%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DSM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DSM.CA Price Earnings VS Forward Price EarningsDSM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DSM.CA Per share dataDSM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DSM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DEEP-SOUTH RESOURCES INC

TSX-V:DSM (3/20/2024, 7:00:00 PM)

0.08

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)02-04 2022-02-04
Inst Owners0.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap0
Analysts84.44
Price Target1.07 (1237.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 11.43
P/tB 11.43
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -712.26%
ROE -753.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-255.92%
ROA(5y)-158.24%
ROE(3y)-281.31%
ROE(5y)-174.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1647.66%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.46
Quick Ratio 8.46
Altman-Z 97.07
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-424.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.34%
OCF growth 3YN/A
OCF growth 5YN/A